Jiangsu Bioperfectus Technologies Co., Ltd. (SHA:688399)

SHA:688399 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	345.77	483.77	810.63	1,769	1,792	1,287
Short-Term Investments	-	-	30.56	-	-	-
Trading Asset Securities	1,367	1,097	1,138	694.81	1,015	623.33
Cash & Short-Term Investments	1,713	1,580	1,979	2,464	2,807	1,911
Cash Growth	-13.85%	-20.15%	-19.69%	-12.22%	46.90%	32.97%
Accounts Receivable	41.44	39.84	53.89	108.71	610	343.63
Other Receivables	6.04	11.27	21.33	26.03	26.31	9.62
Receivables	47.48	51.12	75.23	134.74	636.31	353.25
Inventory	47.09	51.5	67.04	93.86	236.26	250.35
Prepaid Expenses	-	-	-	-	-	0.27
Other Current Assets	19.76	12	17.98	17	29.5	24.19
Total Current Assets	1,828	1,695	2,139	2,710	3,709	2,539
Property, Plant & Equipment	659.74	625.73	577.23	614.61	731.7	714.97
Long-Term Investments	549.83	1,137	885.3	416.48	116.28	122.9
Other Intangible Assets	24.94	26.04	27.45	29.88	27.41	26.82
Long-Term Deferred Tax Assets	57.64	64.78	75.01	80.39	91.63	19.27
Long-Term Deferred Charges	4.19	6.12	34.58	55.12	74.23	54.32
Other Long-Term Assets	597.39	0.08	1.07	0.16	140.6	22.18
Total Assets	3,721	3,554	3,740	3,906	4,891	3,499

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	73.34	24.32	17.56	29.17	327.8	132.5
Accrued Expenses	11.15	51	54.9	89.57	242.53	197.69
Short-Term Debt	463.17	316.74	227.69	156.94	84.89	150
Current Portion of Leases	-	4.73	5.64	7.82	8.38	7.32
Current Income Taxes Payable	2.32	0	0	0	85.37	32.51
Current Unearned Revenue	14.36	17.4	38.76	14.46	38.39	66.21
Other Current Liabilities	25.77	53.38	23.27	65.9	145.24	269.4
Total Current Liabilities	594.21	467.58	367.82	363.87	932.6	855.63
Long-Term Debt	81.12	48.68	-	-	-	-
Long-Term Leases	5.44	6.94	7.22	8.7	10.52	6.9
Long-Term Unearned Revenue	46.85	52.52	64.28	78.24	90.82	86.82
Long-Term Deferred Tax Liabilities	0	0	-	0	16.24	3.53
Other Long-Term Liabilities	50	50	50	50.5	62.68	10
Total Liabilities	777.63	625.71	489.32	501.31	1,113	962.89

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	83.87	83.87	56.67	58.62	58.62	58.62
Additional Paid-In Capital	633.88	633.88	661.06	806.6	805.83	805.83
Retained Earnings	2,231	2,212	2,538	2,540	2,914	1,672
Comprehensive Income & Other	-5.3	-0.76	-4.98	-	-	-
Shareholders' Equity	2,944	2,929	3,251	3,405	3,778	2,536
Total Liabilities & Equity	3,721	3,554	3,740	3,906	4,891	3,499

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	553.83	377.09	240.55	173.46	103.79	164.23
Net Cash (Debt)	1,159	1,203	1,738	2,291	2,703	1,747
Net Cash Growth	-26.58%	-30.79%	-24.11%	-15.26%	54.77%	25.93%
Net Cash Per Share	9.27	9.70	11.72	17.85	21.05	13.61
Filing Date Shares Outstanding	119.5	124.13	124.13	128.4	128.4	128.4
Total Common Shares Outstanding	119.5	124.13	124.13	128.4	128.4	128.4
Working Capital	1,233	1,227	1,771	2,346	2,777	1,683
Book Value Per Share	24.63	23.59	26.19	26.52	29.42	19.75
Tangible Book Value	2,919	2,903	3,223	3,375	3,751	2,510
Tangible Book Value Per Share	24.42	23.38	25.97	26.29	29.21	19.55
Buildings	-	553.39	553.68	551.68	537.05	506.36
Machinery	-	193.26	229.99	236.62	313.41	263.97
Construction In Progress	-	94.92	4.94	1.53	16.99	20.72

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 2, 2026

Data Sources Report a data error